Infigratinib is an investigational oral therapy designed to directly inhibit FGFR3 protein phosphorylation, addressing the underlying cause of achondroplasia.

Optune Pax is a portable medical device that delivers TTFields non-invasively via wearable arrays to disrupt electrical processes essential for cancer cell division.

“BHA has remained in the food supply for decades despite being identified by the National Toxicology Program as ‘reasonably anticipated to be a human carcinogen’ based on animal studies,” U.S.

HealthDay News — The Trump administration plans to take back about $600 million in public health funding from 4 Democrat-led states, saying the grants no longer match health priorities. The states ...

In a joint statement, the organizations said the CDC’s vaccine review process has “effectively collapsed,” making an independent review necessary. For decades, vaccine guidance in the United States ...

Mondelēz Global LLC has expanded a voluntary recall of certain Chips Ahoy! Baked Bites Brookie products sold in the US that may pose a choking hazard. The company said the recall now includes one ...

HealthDay News — More than 4 in 10 people older than 50 years (42%) have not gotten either a flu or COVID-19 vaccine, according to the results of a survey conducted by the University of Michigan ...

More patients receiving tenecteplase versus standard medical treatment had excellent functional outcome at 90 days.

One in four young people taking these medicines were prescribed other medications carrying a risk of serious drug interactions.

Reductions in hot flashes/day and in daily hot flash scores seen with 2.5mg and 5mg oxybutynin versus placebo.

The plea from Oz, a cardiothoracic surgeon, was the most forceful yet for vaccination from an administration that has repeatedly expressed skepticism about vaccine safety and effectiveness. Measles ...

The FDA is expected to decide on treatments for acquired hypothalamic obesity, dry eye disease, primary biliary cholangitis, psoriatic arthritis, and severe leukocyte adhesion deficiency-I.